Search results for "Azole"

showing 10 items of 2392 documents

Multilayered supported ionic liquids as catalysts for chemical fixation of carbon dioxide

2011

Multilayered, covalently supported ionic liquid phase (mlc-SILP) materials were synthesized by using a new approach based on the grafting of bis-vinylimidazolium salts on different types of silica or polymeric supports. The obtained materials were characterized and tested as catalysts in the reaction of supercritical carbon dioxide with various epoxides to produce cyclic carbonates. The material prepared by supporting a bromide bis-imidazolium salt on the ordered mesoporous silica SBA-15 was identified as the most active catalyst for the synthesis of cyclic carbonates and displayed improved productivity compared with known supported ionic liquid catalysts. The catalyst retained its high act…

Vinyl CompoundsMaterials scienceGeneral Chemical EngineeringCatalyst supportIndustrial catalystsInorganic chemistryCarbonatesIonic LiquidsHeterogeneous catalysisCatalysisCatalysischemistry.chemical_compoundsupercritical carbon dioxideEnvironmental ChemistryGeneral Materials ScienceSupported ionic liquidSupercritical carbon dioxidecarbonate synthesiImidazolesSettore CHIM/06 - Chimica OrganicaCarbon DioxideMesoporous silicaSupercritical fluidGeneral EnergychemistryIonic liquidEpoxy CompoundsChemSusChem
researchProduct

Invasive maxillary sinus aspergillosis: a case report successfully treated with voriconazole and surgical debridement

2014

Introduction: Invasive aspergillosis of the paranasal sinuses is a rare disease and often misdiagnosed; however, its incidence has seen substancial growth over the past 2 decades. Definitive diagnosis of these lesions is based on histological examination and fungal culture. Case Report: An 81-year-old woman with a history of pain in the left maxillary region is presented. The diagnosis was invasive maxillary aspergillosis in immunocompetent patient, which was successfully treated with voriconazole and surgical debridement. Possible clinical manifestations, diagnostic imaging techniques and treatment used are discussed. Since the introduction of voriconazole, there have been several reports …

VoriconazoleAntifungalmedicine.medical_specialtyMaxillary sinusbusiness.industrymedicine.drug_classSurgical debridementCase ReportOdontología:CIENCIAS MÉDICAS [UNESCO]Aspergillosismedicine.diseaseCiencias de la saludSurgerymedicine.anatomical_structureParanasal sinusesUNESCO::CIENCIAS MÉDICASMedicineOral SurgerybusinessGeneral Dentistrymedicine.drugRare diseaseHistological examination
researchProduct

Safety of micafungin in prospective and retrospective clinical trials

2012

Summary Managing fungal diseases remains a major challenge for clinicians despite the improved armamentarium of antifungal agents. This review identified 19 publications reporting safety data on micafungin. Two of these publications were spin off publications, the remaining 17 (15 prospective, two retrospective) were included in the main assessment. Major adverse events reported which occurred in more than 2% in the study populations were infusion-related, gastro-intestinal and hepatic (LFT parameters elevations). Micafungin demonstrated significantly less renal events compared with liposomal amphotericin B and less hepatic events compared with voriconazole. Compared with fluconazole no sig…

VoriconazolebiologyEchinocandinbusiness.industryMicafunginDermatologyGeneral Medicinebacterial infections and mycosesbiology.organism_classificationInfectious DiseasesImmunologymedicineChillsmedicine.symptombusinessAdverse effectCandida albicansEchinocandinsFluconazolemedicine.drugMycoses
researchProduct

Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

2010

Abstract Abstract 2309 Objectives. Treatment of invasive aspergillosis (IA) fails in up to 50% of all cases and the mortality rate is at least 30%. Antifungal combination treatment has not been proven to be beneficial and dose escalation with liposomal amphotericin B did not improve outcome. New approaches are needed for patients with severe immunosuppression. Methods. Escalating high dosages of caspofungin were investigated in IA defined according to modified EORTC/MSG criteria. The tested cohort of patients received 70mg, 100mg, 150mg or 200mg QD, 8 patients each were to receive caspofungin first-line treatment for proven/probable IA for up to 28 days. Dose limiting toxicity was defined a…

Voriconazolemedicine.medical_specialtyDosebusiness.industryMortality rateImmunologyCell BiologyHematologyAspergillosismedicine.diseaseBiochemistrySurgerychemistry.chemical_compoundchemistryInternal medicineToxicityCohortmedicineCaspofunginAdverse effectbusinessmedicine.drugBlood
researchProduct

Voriconazole and the liver.

2015

Voriconazole is an azole useful for the prophylaxis and the treatment of aspergillosis and other fungal infections in immunosuppressed subjects, as those found in aplasia after aggressive polychemotherapy treatments, after hematopoietic stem cell, liver or lung transplantation. Its administration in therapeutic doses lead to extremely varied serum levels from patient to patient and even to the same patient. The explanations are varied: nonlinear pharmacokinetics, certain patient-related factors, including genetic polymorphisms in the cytochrome P450 2C19 gene, the kidney and liver function, simultaneous administration with other drugs metabolised by the same cytochrome. It is recommended to…

Voriconazolemedicine.medical_specialtyHepatologymedicine.diagnostic_testbusiness.industryCYP2C19Pharmacologymedicine.diseaseAspergillosisGastroenterologyEditorialCholestasisTherapeutic drug monitoringInternal medicineToxicitymedicineLiver functionbusinessAdverse effectmedicine.drugWorld journal of hepatology
researchProduct

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients

2003

Patients with severe neutropenia lasting for more than 10 days, who develop fever and pulmonary infiltrates, are at high risk of treatment failure and infection-related death, under conventional broad-spectrum antibiotics. Early supplementation by a systemic antifungal therapy active against Aspergillus spp. has been shown to markedly improve their clinical outcome. Prognosis is significantly influenced by early identification of lung infiltrates by means of high-resolution thoracic computed tomography. Non-culture based diagnostic procedures using a highly sensitive Sandwich ELISA assay to detect circulating galactomannan, or PCR techniques to amplify circulating fungal DNA, may facilitate…

Voriconazolemedicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryRespiratory diseaseHematologyGeneral MedicineNeutropeniamedicine.diseaseAspergillosisGastroenterologyBronchoalveolar lavageAmphotericin B deoxycholateInternal medicinemedicinebusinessFebrile neutropeniaMycosismedicine.drugAnnals of Hematology
researchProduct

Successful Topical Application of Caspofungin in the Treatment of Fungal Keratitis Refractory to Voriconazole

2010

Fungal keratitis is an important ophthalmic problem because it leads to corneal blindness and sometimes to loss of the eye.1,2 There is no agreed protocol for the treatment of suspected fungal keratitis. Topical and oral voriconazole have now been reported to be effective.3 However, some cases do not respond to this treatment. New antifungal agents such as caspofungin acetate, 0.5%, are promising alternatives

Voriconazolemedicine.medical_specialtybusiness.industryEye diseaseFongs patògensmedicine.diseasecorneal ulcerCaspofungin AcetateKeratitisSurgeryOphthalmologychemistry.chemical_compoundRefractorychemistrymedicineFungal keratitisCaspofunginbusinessmedicine.drugArchives of Ophthalmology
researchProduct

Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein–Coupled Receptor OGR1 (GPR68)

2016

Background & Aims: A novel family of proton-sensing G-proteinâcoupled receptors, including ovarian cancer G-proteinâcoupled receptor 1 (OGR1) (GPR68) has been identified to play a role in pH homeostasis. Hypoxia is known to change tissue pH as a result of anaerobic glucose metabolism through the stabilization of hypoxia-inducible factor-1α. We investigated how hypoxia regulates the expression of OGR1 in the intestinal mucosa and associated cells. Methods: OGR1 expression in murine tumors, human colonic tissue, and myeloid cells was determined by quantitative reverse-transcription polymerase chain reaction. The influence of hypoxia on OGR1 expression was studied in monocytes/macrophages and…

WT wild type0301 basic medicineMM6 MonoMac 6HV healthy volunteerSPARC secreted protein acidic and rich in cysteineNF-κB nuclear factor-κBInflammationBiologyIEC intestinal epithelial cell03 medical and health sciencesIntestinal mucosaTDAG8Ovarian Cancer G-Protein–Coupled ReceptormedicineOGR1 ovarian cancer G-protein–coupled receptor 1 (GPR68)IFN interferonlcsh:RC799-869ReceptorOriginal ResearchTh T-helperInflammationTNF tumor necrosis factorIBD inflammatory bowel diseaseHepatologyRT-qPCR quantitative reverse-transcription polymerase chain reactionAICAR 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosideTDAG8 T-cell death-associated gene 8 (GPR65)Inflammatory Bowel DiseaseGRP65GastroenterologyHypoxia (medical)Molecular biologyGPR G-protein–coupled receptormRNA messenger RNAIL interleukinChIP chromatin immunoprecipitationHIF hypoxia-inducible factorUC ulcerative colitis030104 developmental biologyHypoxia-inducible factorsCancer researchCD Crohn's diseaselcsh:Diseases of the digestive system. GastroenterologyTumor necrosis factor alphaFCS fetal calf serummedicine.symptomChromatin immunoprecipitationHomeostasisCellular and Molecular Gastroenterology and Hepatology
researchProduct

1-(3′,6′-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9′-xanthen]-5-yl)-3-[4-({4-[1-(4-fluorophenyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)phenyl]thiourea …

2016

The title compound, which crystallized as a methanol monosolvate, C41H27FN6O5S·CH3OH, was synthesized as a probe for a fluorescence polarization-based competition binding assay. The isobenzofuran fused-ring system is close to planar and orientated almost perpendicular to the central ring of the xanthene system. The dihedral angle between the benzene rings of the xanthene system is 10.0 (2)°, indicating a butterfly-like orientation. A short intramolecular C—F...π contact [F...π = 3.100 (4) Å and C—F...π = 139.9 (3)°] to the six-membered ring of the isobenzofuran system may influence the molecular conformation. The methanol solvent molecule is disordered over two orientations in a 0.6:0.4 rat…

Xanthenecrystal structurefluorescein010405 organic chemistryHydrogen bondStereochemistryThio-General MedicineDihedral angle010402 general chemistryRing (chemistry)01 natural sciences0104 chemical scienceschemistry.chemical_compoundchemistryThioureapyridinylimidazoleFuranlcsh:QD901-999lcsh:CrystallographyMethanolthioureaIUCrData
researchProduct

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein.

2021

Cystic fibrosis (CF) is a genetic disease caused by mutations that impair the function of the CFTR chloride channel. The most frequent mutation, F508del, causes misfolding and premature degradation of CFTR protein. This defect can be overcome with pharmacological agents named “correctors”. So far, at least three different classes of correctors have been identified based on the additive/synergistic effects that are obtained when compounds of different classes are combined together. The development of class 2 correctors has lagged behind that of compounds belonging to the other classes. It was shown that the efficacy of the prototypical class 2 corrector, the bithiazole corr-4a, could be impr…

Yellow fluorescent proteinProtein FoldingCystic FibrosisMutantPharmaceutical ScienceCystic Fibrosis Transmembrane Conductance RegulatorCarboxamidemedicine.disease_cause01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundMutant ProteinDrug DiscoveryMoietyCFTR potentiatorCFTRchemistry.chemical_classification0303 health sciencesMutationbiologyChemistryChemistry (miscellaneous)Chloride channelMolecular MedicineHumanStereochemistrymedicine.drug_classCFTR correctorArticleF508del-CFTRlcsh:QD241-44103 medical and health scienceslcsh:Organic chemistrymedicineHumansBenzodioxolesPhysical and Theoretical ChemistryThiazoleCystic Fibrosi030304 developmental biology010405 organic chemistryOrganic ChemistryAminoimidazole Carboxamide0104 chemical sciencesThiazolesMutationbiology.proteinMutant ProteinsBenzodioxoleTricyclicMolecules (Basel, Switzerland)
researchProduct